P11 (S100A10) as a potential predictor of ketamine response in patients with SSRI-resistant depression.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of affective disorders"
DOI: 10.1016/j.jad.2021.04.055
Abstract: BACKGROUND Ketamine can act as antidepressant in patients with major depressive disorder (MDD) who are treatment-resistant. P11 has been implicated in ketamine's mechanism of action and proposed as biomarker for treatment response to other antidepressants.… read more here.
Keywords: response; treatment; ketamine; p11 levels ... See more keywords